153 related articles for article (PubMed ID: 37701109)
1. Integrative analysis of the SOX family-related prognostic signature and immunological infiltration in prostate cancer.
Li Z; Wang F
Transl Cancer Res; 2023 Aug; 12(8):2048-2062. PubMed ID: 37701109
[TBL] [Abstract][Full Text] [Related]
2. Multi-Omics Approaches Identify Necroptosis‑Related Prognostic Signature and Associated Regulatory Axis in Cervical Cancer.
Zhan J; Yang F; Ge C; Yu X
Int J Gen Med; 2022; 15():4937-4948. PubMed ID: 35592536
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
Chen Y
Front Genet; 2022; 13():912037. PubMed ID: 35937995
[No Abstract] [Full Text] [Related]
4. Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma.
Luo P; Jiang Y; Ding S; Jiang S; Tang R; Tang Z
Biomed Res Int; 2022; 2022():4944758. PubMed ID: 35692583
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of the molecular subtype and prognostic signature for clear cell renal cell carcinoma based on neutrophil extracellular traps.
Quan J; Huang B
Front Cell Dev Biol; 2022; 10():1021690. PubMed ID: 36523511
[No Abstract] [Full Text] [Related]
6. A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer.
Ren L; Yang X; Wang W; Lin H; Huang G; Liu Z; Pan J; Mao X
Front Genet; 2023; 14():1096783. PubMed ID: 36911392
[No Abstract] [Full Text] [Related]
7. The role of SOX family members in solid tumours and metastasis.
Grimm D; Bauer J; Wise P; Krüger M; Simonsen U; Wehland M; Infanger M; Corydon TJ
Semin Cancer Biol; 2020 Dec; 67(Pt 1):122-153. PubMed ID: 30914279
[TBL] [Abstract][Full Text] [Related]
8. Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma.
Ren Z; Wang Z; Gu D; Ma H; Zhu Y; Cai M; Zhang J
Front Cell Dev Biol; 2021; 9():740455. PubMed ID: 34746134
[No Abstract] [Full Text] [Related]
9. Long Non-coding RNAs LINC01679 as a Competitive Endogenous RNAs Inhibits the Development and Progression of Prostate Cancer via Regulating the miR-3150a-3p/SLC17A9 Axis.
Mi YY; Sun CY; Zhang LF; Wang J; Shao HB; Qin F; Xia GW; Zhu LJ
Front Cell Dev Biol; 2021; 9():737812. PubMed ID: 34900992
[TBL] [Abstract][Full Text] [Related]
10. Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma.
Cheng X; Zeng Z; Yang H; Chen Y; Liu Y; Zhou X; Zhang C; Wang G
BMC Cancer; 2023 Jan; 23(1):105. PubMed ID: 36717792
[TBL] [Abstract][Full Text] [Related]
11. UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer.
Wang Z; Wang Y; Peng M; Yi L
Front Oncol; 2019; 9():1517. PubMed ID: 32010618
[No Abstract] [Full Text] [Related]
12. Identification and Verification of Necroptosis-Related Gene Signature and Associated Regulatory Axis in Breast Cancer.
Hu T; Zhao X; Zhao Y; Cheng J; Xiong J; Lu C
Front Genet; 2022; 13():842218. PubMed ID: 35251139
[No Abstract] [Full Text] [Related]
13. Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma.
Zeng C; Liu Y; He R; Lu X; Dai Y; Qi G; Liu J; Deng J; Lu W; Jin J; Liu Q
Front Genet; 2022; 13():935056. PubMed ID: 36092903
[No Abstract] [Full Text] [Related]
14. Mining Database to Identify Aging-Related Molecular Subtype and Prognostic Signature in Lung Adenocarcinoma.
Feng C; Che W; Liang H; Zhang H; Lan C; Wu B; Lin W; Chen Y
J Oncol; 2022; 2022():9142903. PubMed ID: 36268280
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the FOXA1-related ceRNA network and identification of the MAGI2-AS3/DUSP2 axis as a prognostic biomarker in prostate cancer.
Yang G; Chen X; Quan Z; Liu M; Guo Y; Tang Y; Peng L; Wang L; Wu Y; Wu X; Liu J; Zheng Y
Front Oncol; 2023; 13():1048521. PubMed ID: 36998469
[TBL] [Abstract][Full Text] [Related]
16. Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer.
Kang Z; Sun JB; Lin F; Huang XY; Huang Q; Chen DN; Zheng QS; Xue XY; Xu N; Wei Y
Front Oncol; 2023; 13():1160972. PubMed ID: 37346077
[TBL] [Abstract][Full Text] [Related]
17. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
[TBL] [Abstract][Full Text] [Related]
18. Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer.
Chen G; Qin X; Wang Y; Gao B; Ling M; Yin W; Li Y; Pan B
Cell Cycle; 2022 Aug; 21(16):1684-1696. PubMed ID: 35414328
[TBL] [Abstract][Full Text] [Related]
19. Immune-Related Genes Are Prognostic Markers for Prostate Cancer Recurrence.
Fu M; Wang Q; Wang H; Dai Y; Wang J; Kang W; Cui Z; Jin X
Front Genet; 2021; 12():639642. PubMed ID: 34490029
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
